TC Biopharm   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Holytown United Kingdom (2013)

Organization Overview

First Clinical Trial
2015
NCT02459067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TC Biopharm